MiNK Therapeutics, Inc. logo

INKTMiNK Therapeutics, Inc.

INKT Stock Price, Valuation & Chart | MiNK Therapeutics, Inc.

Compare

INKT Historical price chart

INKT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization56.44M
PE Ratio-4.8
EPS-2.36
Trading Volume8.26K
Today's High/Low11.51/10.82
Dividend Yield0.00
52 Week High/Low16.98/8.48
Shares Outstanding4.98M
INKT Financial Statement
INKT Analyst ratings
INKT Analysis & performance metrics

INKT Company profile

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant…

INKT Management team

Management
Christine M. Klaskin
Treasurer and Principal Financial & Accounting Officer
Eleni Chantzoura Ph.D.CTO
Director & Head of Discovery
Garo H. Armen Ph.D.
Executive Chairman
Jennifer S. Buell Ph.D.CEO
President, Chief Executive Officer & Director
Total 4 executives

INKT Frequently asked questions

What is MiNK Therapeutics, Inc. (INKT) Stock Price?

Current stock price of MiNK Therapeutics, Inc. (INKT) stock is $11.330. The stock price is +3.47% higher in the session. The intraday range can be seen from this page. Volume of MiNK Therapeutics, Inc. (INKT) stock is 8.26K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the MiNK Therapeutics, Inc. (INKT) stock price going up or down today?

The stock price of MiNK Therapeutics, Inc. (INKT) can change with earnings, company news, and overall market sentiment. MiNK Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the MiNK Therapeutics, Inc. stock expensive at its current price?

Whether MiNK Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for INKT on this page is -4.80. EPS on this page is -2.36. Compare those figures with peers and growth expectations before deciding if the current MiNK Therapeutics, Inc. price is justified.

How has the stock price of MiNK Therapeutics, Inc. (INKT) performed historically?

Historical performance for MiNK Therapeutics, Inc. (INKT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how INKT reacted to past earnings and market events.

Should I buy MiNK Therapeutics, Inc. (INKT) stock, at this price?

Buying MiNK Therapeutics, Inc. (INKT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.